Mitesh

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Estradot® 25micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 3rd April 2025, SSP082, provides that for every Estradot® 25micrograms/24hours patch originally prescribed either one Evorel® 25 patch or one Estraderm® MX [...]

The post SSP for Estradot® 25micrograms/24hours patch issued appeared first on Community Pharmacy England.

From 1 April 2025,  Progesterone micronised 200mg capsules (Gepretix®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the April 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to [...]

The post Progesterone micronised 200mg capsules (Gepretix®) added to the HRT PPC medicines list from April 2025 appeared first on Community Pharmacy England.